Rad18-dependent SUMOylation of human specialized DNA polymerase eta is required to prevent under-replicated DNA.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 27811911.
- Also identified by DOI 10.1038/ncomms13326 and PMC identifier 5097173.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Translesion polymerase eta (polη) was characterized for its ability to replicate ultraviolet-induced DNA lesions that stall replicative polymerases, a process promoted by Rad18-dependent PCNA mono-ubiquitination. Recent findings have shown that polη also acts at intrinsically difficult to replicate sequences. However, the molecular mechanisms that regulate its access to these loci remain elusive. Here, we uncover that polη travels with replication forks during unchallenged S phase and this requires its SUMOylation on K163. Abrogation of polη SUMOylation results in replication defects in response to mild replication stress, leading to chromosome fragments in mitosis and damage transmission to daughter cells. Rad18 plays a pivotal role, independently of its ubiquitin ligase activity, acting as a molecular bridge between polη and the PIAS1 SUMO ligase to promote polη SUMOylation. Our results provide the first evidence that SUMOylation represents a new way to target polη to replication forks, independent of the Rad18-mediated PCNA ubiquitination, thereby preventing under-replicated DNA.
Medical subject headings
- DNA Replication
- DNA-Binding Proteins
- DNA-Directed DNA Polymerase
- Proliferating Cell Nuclear Antigen
- Protein Inhibitors of Activated STAT
- Small Ubiquitin-Related Modifier Proteins
- Ubiquitin-Protein Ligases